Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 135-138

  Cantón, Emilia ^a   Pemán, Javier ^a   Espinel Ingroff, Ana ^b   Martín Mazuelos, Estrella ^c   Carrillo Muñoz, Alfonso ^d   Martínez, José Pedro ^e  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d Associacio Catalana d'Intelligencia Artificial   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Azoles; M44 A; Susceptibility

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KEFYR; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA TROPICALIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DILUTION; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH INHIBITION; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MYCOLOGY; NONHUMAN; PICHIA; REPRODUCIBILITY; RHODOTORULA GLUTINIS; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE; TIME; TRICHOSPORON ASAHII; YARROWIA LIPOLYTICA;

ANTIBIOTICS, ANTIFUNGAL; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TRIAZOLES;

EID: 37548998574     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm442     Document Type: Article

References (16)

1. Cantón E, Peman J, Orero A et al. Actividad in vitro de posaconazol frente a levaduras aisladas de hemocultivo. Rev Esp Quimioter 2002; 15: 335-40.
2. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950-6.
3. Manavathu EK, Cutright JL, Loebenberg D et al. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592). J Antimicrob Chemother 2000; 46: 229-34.
4. Sabatelli F, Patel R, Mann P et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009-15.
5. Greenberg RN, Mullane K, van Burik JA et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126-33.
6. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast - Second Edition: Approved Standard M27-A2. NCCLS, Wayne, PA, USA, 2002.
7. National Committee for Clinical Laboratory Standards. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline M44-A. NCCLS, Wayne, PA, USA, 2004.
8. Cantón E, Pemán J, Gobernado M et al. Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob Agents Chemother 2004; 48: 2477-82.
9. Rex JH, Cooper CR Jr, Merz WG et al. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother 1995; 39: 906-9.
10. Clinical and Laboratory Standards Institute. Quality Control Minimal Inhibitory Concentration (MIC) Limits for Broth Microdilution and MIC interpretive Breakpoints: Supplement M27-S2. CLSI, Wayne, PA, USA, 2006.
11. Brown S, Traczewski M. Quality control limits for posaconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol 2007; 45: 222-3.
12. Clinical and Laboratory Standards Institute. Zone Diameter Interpretative Standards and Corresponding Minimal Inhibitory Concentration (MIC) Interpretative Breakpoints: Supplement M44-S1. CLSI, Wayne, PA, USA, 2006.
13. Sims CR, Paetznick VL, Rodriguez JR et al. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol 2006; 44: 2105-8.
14. Espinel-Ingroff A. Comparison of three commercial (Etest, YeastOne and Neo-Sensitabs tablet) and disk diffusion (modified M44-A) assays with reference (CLSI M38-A and M27-A2 microdilution) MICs for testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 2006; 44: 3616-22.
15. Lopez-Oviedo E, Aller AI, Martin C et al. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: Comparison with CLSI broth microdilution method. Antimicrob Agents Chemother 2006; 50: 1108-11.
16. Diekema DJ, Messer SA, Hollis RJ et al. Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole. J Clin Microbiol 2007; 45: 1974-7.